XGN (Exagen Diagnostics) Company Assets

XGN (Exagen Inc.) - company brandmark

Exagen Inc. (XGN) laboratory facilities in the United States specialize in detecting autoimmune pathologies by leveraging proprietary biomarkers. This process is complemented by the Avise digital environment, which integrates high-precision tests with intelligent analysis for clinics. Experienced biochemists and a strong sales department ensure business stability. This chart of the current share price shows that total assets reach 55.34, confirming the resilience of the company's human capital.

XGN - Exagen Company Total Assets over the range 07/04/2022 - 10/31/2026

Financial and market metric breakdowns for exagen.com (XGN)

- price and consensus price forecast:
Stock Quotes Exagen|XGN - Analyst Consensus Forecast
- business market valuation indicators:
Market Value XGN|XGN - Enterprise Value
- balance sheet equity data:
Equity per Share Exagen Inc.|XGN - Book Capitalization|Market Capitalization to Book Value Ratio exagen.com|XGN - Aggregate Company Assets
- debt burden and liquidity indicators:
Debt to Equity Ratio Exagen Inc.|XGN - Long-Term Debt to Capital|Short-Term Debt to Capital Exagen|XGN - Company Debts|Debt to Book Capitalization Ratio XGN|XGN - Company Long-Term Liabilities|Short-Term Debt Exagen Inc.|Interim Coverage Ratio exagen.com
- earnings and market ratios statistics:
XGN - Net Profit
Basic company analysis:Exagen Diagnostics, XGN
Brand item of exagen.com

Total assets represent the aggregate value of the company's resources, calculated inversely via the return on assets (ROA). For Exagen Inc. (XGN), this metric reflects capital management efficiency while actively utilizing external logistics and IT partners. The trend in gross assets allows for an assessment of the business's physical scale and its ability to scale. It is critical for investors to correlate resource growth with debt load risks to confirm the quality of the fundamental base.

Key competitors

Cumulative Company Assets agilent.com|DGX (Quest Diagnostics Incorporated) - Company Total Assets|Company Assets Illumina Inc ILMN|Company Total Assets EXAS|Revvity Corp - Total Business Assets|Company Total Assets BIO (Bio-Rad Laboratories)|Company Total Assets anbio.com NNNN|SHC - Aggregate Company Assets|QDEL (Quidel Corporation) - Total Business Assets|OPK: Company Total Assets|CareDx, Inc. (CDNA) - Company Total Assets|Aggregate Company Assets Maravai LifeSciences|Aggregate Company Assets FLGT|Cumulative Company Assets LAB (Standard BioTools)|CTKB - Company Assets|Aggregate Company Assets OraSure Technologies Inc OSUR|Company Total Asset Base MDxHealth, Inc. (MDXH)|Lucid Diagnostics Inc. - Company Total Assets|Company Total Asset Base Prenetics Global PRE|imdxinc.com (IMDX) - Aggregate Company Assets|TRIB - Company Total Asset Base|PRPH (ProPhase) - Company Total Assets|Company Assets Ainos Corporation AIMD|Cumulative Company Assets CODX (Co-Diagnostics, Inc.)|heartsciences.com - Total Business Assets|Company Total Assets BMRA (Biomerica)|Company Total Assets Cardio Diagnostics Holdings Inc. CDIO|Virax Biolabs Group Ltd - Company Total Assets|Company Balance Sheet Assets Bluejay Diagnostics Corp (BJDX)|AWH: Company Total Assets|Company Assets acceleratediagnostics.com (AXDX)|Aggregate Company Assets CENTOGENE N.V.|Total Business Assets ENZ (Enzo)|Cumulative Company Assets FRES (Fresh2 Group Limited)|GENE (gtglabs.com) - Aggregate Asset Value|Company Total Assets ME (23andMe Holding Co.)|Company Total Asset Base psychemedics.com (PMD)